InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,214.08
(
0.51%
)
US TECH 100
17,658.00
(
0.32%
)
Dow Jones
39,387.76
(
0.85%
)
Brent Oil
84.27
(
0.38%
)
Bitcoin
62,827.39
(
-0.35%
)
Post# of 251777
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

vinmantoo

Send PM Follow Ignore
Followers 30
Posts 4081
Boards Moderated 0
Alias Born 07/25/2007

vinmantoo

Re: None

Monday, 05/23/2022 5:42:15 PM

Monday, May 23, 2022 5:42:15 PM

Post# of 251777
IMGN has its BLA application accepted with priority review for their single arm trial of mirvetuximab soravtansine in platinum resistant ovarian cancer patients whose tumors express high levels of alpha folate receptor .

https://finance.yahoo.com/news/immunogen-announces-acceptance-biologics-license-103000061.html
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up